Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-69.64	19.25	63.38
Graham Fair Price	41.42	44.41	31.40
PEG	55.52	0.09	0.06
Price/Book	-27.36	6.86	9.44
Price/Cash Flow	-63.40	19.25	52.59
Prices/Earnings	-63.68	8.87	24.41
Price/Sales	-63.68	3.90	10.74
Price/FCF	-63.40	19.25	52.59
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.26	0.26
Operating Margin	0.71	0.16	0.16
ROA	100.00	0.08	0.04
ROE	0.10	0.19	100.00
ROIC	0.09	0.17	94.96
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.36	-0.46	-22.64
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	13.62	1.01	-92.55
EPS QOQ	4.28	1.00	-76.65
FCF QOQ	4.70	0.98	-79.03
Revenue QOQ	-0.20	1.00	398.61
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	48.35	24.17	-50.00
Days Sales Outstanding (DSO)	69.12	36.81	-46.75
Inventory Turnover	1.86	3.72	100.00
Debt/Capitalization	0.09	0.12	31.44
Quick Ratio	1.19	1.25	5.42
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	21.29	21.29	< 0.005
Cash	6.38	6.57	2.99
Capex	-0.42	-0.84	-100.00
Free Cash Flow	3.82	7.59	98.46
Revenue	18.72	37.44	100.00
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.71	1.71	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.35	-0.46	65.84
Naive Interpretation	Member

06 - Financial Health · Weak

Rating